Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank100
Studio
Year-over-Year Change

Return on equity

Latest
6.05%
↑ 103% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-239.81%
Historical baseline
PeriodValueYoY Change
20256.05%+107.0%
2024-86.58%+68.1%
2023-271.76%+29.2%
2022-383.92%-2.2%
2021-375.69%-122.8%
2020-168.60%+81.1%
2019-890.18%-1023.9%
2018-79.21%-131.3%
2017-34.25%+70.0%
2016-114.00%-